Massachusetts General Hospital, MGH Banner Patient Care Services Address 55 Fruit Street Boston MA 02114
  Home > Nursing > Oncology > Outpatient Infusion > Cancer Center Adult Infusion Unit, Yawkey, 8E
 
     
 

Nursing Director:
Joanne Perri LaFrancesca RN, MS


PROFILE
Yawkey 8E is a 60 bed/chair infusion unit in the Division of of Hematology-Oncology. The hours of operation are Monday through Thursday from 8 AM to 8 PM and Friday and Saturday from 8 AM to 6 PM. There are 18 beds and 42 chairs.

UNIT FOCUS
Adult cancer patients are referred to the Infusion Units from the oncology practices in the Division of Hematology and Oncology. Patients are referred for treatment with and management of toxicities from chemotherapy and biotherapy.

Patients are followed throughout the entire trajectory of their illness:

Operations Coordinator:
Sheena Smead, BA

Clinical Nurse Specialist:

 

 


diagnosis and treatment, rehabilitation, long-term follow-up, and when necessary, palliative care. There is a strong commitment to primary nursing. Patient readily indentify providing care and are as diverse ad the range of needs patients express.

These disciplines include social service, nutrition, psychiatry, palliative care service, pain service, occupational and physical therapy, and Chaplaincy. Patients who are treated with chemotherapy and biotherapy for malignant disease are also referred to th Infusion Units for treatment related or supportive therapies such as blood products, hydration, antibiotic therapy, and pain managment. Common nursing problems are related to the primary disease and/or treatment-related symptopms,
and include:

  • Protective mechanisms: Alterations in mobility, skin integrity and neurologic status; and myelosuppression
  • GI and GU Function: Alteration in elimination and nutrition
  • Cardiopulmonary Function: Alteration in ventilation and circulation
  • Oncologic Emergencies: hypercalcemia, DIC, SIADH, sepsis, tumon lysis syndrome, hypersensitivity reactions, cord compression, ICP, cardiac tamponade, and SVC syndrome
  • Quality of Life: Sexuality, pain, fatique, altered body image, coping

Staff nurses support the organizational mission and the Cancer Center investment in clinical research. In tandem with the Cancer Center Protocol Office and the Research Manager, staff nurses participate in the administration of all phases of clinical trials on which their primary patients may be enrolled. The Infusion Unit nurse is responsible for patient education, medication administration, symptoom management, and documentation of toxicities for those patients participating in clinical trials as those patients receiving standard regimens.

PATIENT CARE DELIVERY MODEL
Nurses are committed to primary nursing and work in a collaborative practice model with physicians and nurse practitioners, in the Division of Hematology-Oncology.

Nursing care is guided by institutional and national standards. These standards of care include those developed by the MGH Department of Nursing and the national standards of care developed by the MGH Department of Nursing and the national standards of care developed by the Oncology Nursing Society with the American Nurses Association.

Nurses who are assigned to the Infusion Units will be certified in chemotherapy administration and blood product administration as described by The Norman Knight Nursing Center for Clinical & Professional Development (CCPD).

TEAM MEMBERS
Registered nurses (RNs) who are certified in the administration of chemotherapy and blood products work in collaborative practice with oncologists and nurse practitioners. Patient Care Associates, directed by the RN, support the RN in delivering patient care. An olcology Care Coordinator is available to assist the nursing/medical staff with planning patient' complex home care needs, including home IV therapy, prescription drug reimbursement, and facilitate referrals.

A Nursing Director, two clinical nurse specialist and an operations coordinator make up the management triad. This team is responsible for establishing standards of care, initiating quality improvement projects, and setting/supporting the overall tone for patient care. To inquire about positions available on this unit, contact Jeff Hickey at jjhickey@partners.org.

SCHEDULING PRACTICES
The unit budget is prepared and negotiated annually prior to beginning of the fiscal year using current and historical data and trends in volume (workload) and resource utilization and in concert with unit, departmental, and hospital goals and projections (personnel budget, FTE budget). Performance against budget is reviewed and adjusted during the fiscal year as needed based on major changes in activity, resource requirements, goals, or projections.

STAFF ORIENTATION
Nurse orientation to the Infusion Units requires a minimum of six weeks. New nurse employees to the MGH will be required to attend Hospital New Employee Orientation, General Nursing Orientation through CCPD, and a unit-based orientation. Transfers from other nursing units within MGH where chemotherapy administration is included in the scope of practice will require orientation to the Infusion Units.

RNs are expected to have completed both Hospital Orientation and Nursing Orientation and the associated competencies before proceeding to Unit orientation. Successful completion of Unit-based orientation requires (but is not limited to) completion of chemotherapy, blood product, research, and ambulatory infusion competencies.

PCA Orientation requires a minimum of four weeks. PCAs are expected to have completed both Hospital Orientation and Nursing Orientation and the associated competencies before proceeding to Unit orientation.

Practice Assistant orientation requires a minimum of four weeks. Orientees are expected to have completed Hospital Orientation before completing the Unit orientation.

EDUCATIONAL AND DEVELOPMENT OPPORTUNITIES
Infusion Unit staff nurses support the organizational mission and the Cancer Center investment in clinical research. To that end, nurses are provided with education from the Research Nursing Director and designated clinical research nurses, which includes didactic information and clinical precepting. This is done on an individual basis because of the growth in the number and complexity of clinical trials, the evolving nature of experimental cancer therapies, and the Infusion Unit's commitment to disease-focused treatment teams. Thus, the disease-related collaborative practices develop proficiency in the trials associated with their clinical focus.